Literature DB >> 15493365

Beyond hematoxylin and eosin--the role of immunohistochemistry in surgical pathology.

Shabnam Jaffer1, Ira J Bleiweiss.   

Abstract

Immunohistochemistry, a technique that microscopically detects cellular constituents via specific antibodies, has revolutionized the field of surgical pathology by tremendously empowering the hematoxylin and eosin (H&E) slide. In the investigation of the unknown primary, it enables detecting the origin of the tumor by use of tissue- or organ-specific antibodies as well as antibodies associated with minimal histogenetic differentiation. It has almost perfected the pathologist's ability to make specific diagnoses such as those of mesothelioma, melanoma, and neuroendocrine tumors. These diagnoses should be reached by interpreting the immunohistochemical results in the context of a detailed morphological analysis and differential diagnosis based on the H&E. Other important uses include detection of microinvasive and micrometastatic disease. Through the use of prognostic markers, immunohistochemistry can provide valuable information regarding tumor behavior and therapy. Lastly, immunohistochemistry serves a small but valuable role in highlighting microorganisms, particularly viruses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15493365     DOI: 10.1081/cnv-200034896

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  5 in total

1.  Morphological, functional and metabolic imaging biomarkers: assessment of vascular-disrupting effect on rodent liver tumours.

Authors:  Huaijun Wang; Junjie Li; Feng Chen; Frederik De Keyzer; Jie Yu; Yuanbo Feng; Johan Nuyts; Guy Marchal; Yicheng Ni
Journal:  Eur Radiol       Date:  2010-02-25       Impact factor: 5.315

2.  Immunohistochemistry as an important tool in biomarkers detection and clinical practice.

Authors:  Leandro Luongo de Matos; Damila Cristina Trufelli; Maria Graciela Luongo de Matos; Maria Aparecida da Silva Pinhal
Journal:  Biomark Insights       Date:  2010-02-09

Review 3.  Oncologist's/haematologist's view on the roles of pathologists for molecular targeted cancer therapy.

Authors:  Ulrich Keller; Nikolas von Bubnoff; Christian Peschel; Justus Duyster
Journal:  J Cell Mol Med       Date:  2010-02-16       Impact factor: 5.310

4.  Conventional histological and cytological staining with simultaneous immunohistochemistry enabled by invisible chromogens.

Authors:  Larry E Morrison; Mark R Lefever; Heather N Lewis; Monesh J Kapadia; Daniel R Bauer
Journal:  Lab Invest       Date:  2021-12-28       Impact factor: 5.662

Review 5.  Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) to select the optimal patients for matched therapy?

Authors:  Young Kwang Chae; Ayush Arya; Lauren Chiec; Hiral Shah; Ari Rosenberg; Sandip Patel; Kirtee Raparia; Jaehyuk Choi; Derek A Wainwright; Victoria Villaflor; Massimo Cristofanilli; Francis Giles
Journal:  Oncotarget       Date:  2017-08-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.